Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02311621
Title Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications

neuroblastoma

ganglioneuroblastoma

Therapies

CE7R CAR T cells

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.